Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The prolactin receptor (PRLR) is a type I cytokine receptor that mediates the effects of prolactin, growth hormone, and placental lactogen. It is essential for mammary gland development and lactation, and also plays roles in metabolism, immune response, and reproduction. Aberrant PRLR signaling is implicated in various cancers, particularly breast cancer, where it promotes cell proliferation, migration, and invasion. PRLR is being explored as a therapeutic target, with antibody-drug conjugates showing promise in treating PRLR-positive breast cancers.
Targeting PRLR signaling to inhibit cell proliferation, migration, and invasion in cancer cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prolactin Receptor (PRLR).